Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Sep-24 4:15 PM View:  | Verona Pharma Plc (VRNA) | 11-Sep-24 | Sale (Planned) | 600,000 | $3.76 | $2,254,320.00 | (4%) 15.85M to 15.25M | |
| 14-Aug-24 4:16 PM View: | Verona Pharma Plc (VRNA) | 13-Aug-24 | Sale (Planned) | 398,400 | $3.20 | $1,275,680.00 | (2%) 16.25M to 15.85M | |
| 14-Aug-24 4:16 PM View: | Verona Pharma Plc (VRNA) | 12-Aug-24 | Sale (Planned) | 1,600 | $3.13 | $5,008.00 | (< 1%) 16.25M to 16.25M | |
| 09-Aug-24 7:13 PM View: | Verona Pharma Plc (VRNA) | 07-Aug-24 | Grant | 800,000 | -- | -- | 5% 15.77M to 16.57M | |
| 09-Aug-24 7:13 PM View: | Verona Pharma Plc (VRNA) | 07-Aug-24 | Payment of Exercise | 314,800 | $2.62 | $824,776.00 | (2%) 16.57M to 16.25M | |
| 05-Aug-24 9:29 PM View: | Verona Pharma Plc (VRNA) | 01-Aug-24 | Payment of Exercise | 88,544 | $2.83 | $250,801.00 | (< 1%) 15.85M to 15.77M | |
| 03-May-24 7:19 PM View: | Verona Pharma Plc (VRNA) | 01-May-24 | Payment of Exercise | 88,544 | $1.93 | $171,005.00 | (< 1%) 15.94M to 15.85M | |
| 05-Feb-24 6:11 PM View: | Verona Pharma Plc (VRNA) | 01-Feb-24 | Payment of Exercise | 480,200 | $2.29 | $1,101,480.00 | (3%) 16.42M to 15.94M | |
| 03-Nov-23 8:09 PM View: | Verona Pharma Plc (VRNA) | 01-Nov-23 | Payment of Exercise | 809,008 | $1.74 | $1,410,750.00 | (5%) 17.23M to 16.42M | |
| 24-Oct-23 4:06 PM View: | Verona Pharma Plc (VRNA) | 20-Oct-23 | Grant | 800,000 | -- | -- | 5% 16.43M to 17.23M | |
| 07-Aug-23 9:17 PM View: | Verona Pharma Plc (VRNA) | 07-Aug-23 | Sale (Planned) | 8,616 | $2.47 | $21,263.40 | (< 1%) 16.44M to 16.43M | |
| 07-Aug-23 9:17 PM View: | Verona Pharma Plc (VRNA) | 04-Aug-23 | Sale (Planned) | 150,000 | $2.50 | $374,880.00 | (< 1%) 16.59M to 16.44M | |
| 07-Aug-23 9:17 PM View: | Verona Pharma Plc (VRNA) | 03-Aug-23 | Sale (Planned) | 117,272 | $2.54 | $297,754.00 | (< 1%) 16.71M to 16.59M | |
| 03-Aug-23 8:29 PM View: | Verona Pharma Plc (VRNA) | 02-Aug-23 | Sale (Planned) | 73,704 | $2.59 | $191,114.00 | (< 1%) 16.78M to 16.71M | |
| 03-Aug-23 8:29 PM View: | Verona Pharma Plc (VRNA) | 01-Aug-23 | Sale (Planned) | 105,944 | $2.68 | $283,824.00 | (< 1%) 16.89M to 16.78M | |
| 03-May-23 10:00 PM View: | Verona Pharma Plc (VRNA) | 01-May-23 | Sale (Planned) | 455,536 | $2.58 | $1,173,420.00 | (3%) 17.34M to 16.89M | |
| 03-Feb-23 6:18 PM View: | Verona Pharma Plc (VRNA) | 01-Feb-23 | Sale (Planned) | 432,928 | $2.56 | $1,107,080.00 | (2%) 17.78M to 17.34M | |
| 21-Dec-22 4:06 PM View: | Verona Pharma Plc (VRNA) | 20-Dec-22 | Sale (Planned) | 600,000 | $2.12 | $1,269,600.00 | (3%) 18.38M to 17.78M | |
| 03-Nov-22 4:06 PM View: | Verona Pharma Plc (VRNA) | 01-Nov-22 | Payment of Exercise | 454,856 | $1.60 | $727,770.00 | (2%) 18.86M to 18.41M | |
| 03-Nov-22 4:06 PM View: | Verona Pharma Plc (VRNA) | 01-Nov-22 | Sale (Planned) | 32,904 | $1.67 | $55,035.20 | (< 1%) 18.41M to 18.38M | |
| 28-Sep-22 4:05 PM View: | Verona Pharma Plc (VRNA) | 26-Sep-22 | Grant | 3,600,000 | -- | -- | 24% 15.26M to 18.86M | |
| 11-Aug-22 9:46 PM View: | Verona Pharma Plc (VRNA) | 09-Aug-22 | Sale (Planned) | 600,000 | $1.75 | $1,050,000.00 | (4%) 15.86M to 15.26M | |
| 03-Aug-22 4:12 PM View: | Verona Pharma Plc (VRNA) | 01-Aug-22 | Payment of Exercise | 454,864 | $0.67 | $305,896.00 | (3%) 16.35M to 15.9M | |
| 03-Aug-22 4:12 PM View: | Verona Pharma Plc (VRNA) | 01-Aug-22 | Sale (Planned) | 32,904 | $0.70 | $23,026.20 | (< 1%) 15.9M to 15.86M | |
| 05-May-22 7:20 PM View: | Verona Pharma Plc (VRNA) | 03-May-22 | Sale (Planned) | 32,904 | $0.50 | $16,307.20 | (< 1%) 16.38M to 16.35M | |
| 03-May-22 8:17 PM View: | Verona Pharma Plc (VRNA) | 01-May-22 | Payment of Exercise | 454,864 | $0.52 | $237,666.00 | (3%) 16.84M to 16.38M | |
| 03-Feb-22 5:56 PM View: | Verona Pharma Plc (VRNA) | 03-Feb-22 | Sale (Planned) | 52,056 | $0.73 | $37,771.80 | (< 1%) 16.89M to 16.84M | |
| 03-Feb-22 5:56 PM View: | Verona Pharma Plc (VRNA) | 01-Feb-22 | Grant | 334,448 | $0.75 | $250,000.00 | 2% 16.85M to 17.18M | |
| 03-Feb-22 5:56 PM View: | Verona Pharma Plc (VRNA) | 01-Feb-22 | Payment of Exercise | 288,648 | $0.78 | $224,077.00 | (2%) 17.18M to 16.89M | |
| 03-Nov-21 7:52 PM View: | Verona Pharma Plc (VRNA) | 02-Nov-21 | Sale (Planned) | 52,056 | $0.64 | $33,373.10 | (< 1%) 16.9M to 16.85M | |
| 03-Nov-21 7:52 PM View: | Verona Pharma Plc (VRNA) | 01-Nov-21 | Payment of Exercise | 454,848 | $0.64 | $291,103.00 | (3%) 17.35M to 16.9M | |
| 04-Aug-21 8:12 PM View: | Verona Pharma Plc (VRNA) | 04-Aug-21 | Sale (Planned) | 18,400 | $0.74 | $13,674.90 | (< 1%) 17.39M to 17.37M | |
| 04-Aug-21 8:12 PM View: | Verona Pharma Plc (VRNA) | 03-Aug-21 | Sale (Planned) | 16,000 | $0.76 | $12,209.60 | (< 1%) 17.4M to 17.39M | |
| 04-Aug-21 8:12 PM View: | Verona Pharma Plc (VRNA) | 01-Aug-21 | Payment of Exercise | 454,848 | $0.79 | $357,056.00 | (3%) 17.86M to 17.4M | |
| 05-May-21 4:06 PM View: | Verona Pharma Plc (VRNA) | 04-May-21 | Sale (Planned) | 52,056 | $0.81 | $41,925.90 | (< 1%) 17.91M to 17.86M | |
| 05-May-21 4:06 PM View: | Verona Pharma Plc (VRNA) | 03-May-21 | Payment of Exercise | 2,139,630 | $0.89 | $1,898,920.00 | (11%) 20.05M to 17.91M | |
| 03-Mar-21 8:03 PM View: | Verona Pharma Plc (VRNA) | 01-Mar-21 | Sale (Planned) | 43,392 | $1.14 | $49,627.40 | (< 1%) 20.09M to 20.05M | |
| 01-Feb-21 8:54 PM View: | Verona Pharma Plc (VRNA) | 28-Jan-21 | Grant | 529,104 | -- | -- | 3% 19.57M to 20.09M | |
| 12-Nov-19 4:42 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 76,647 | -- | -- | (100%) 76.65K to 0 | |
| 02-Oct-19 4:21 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 01-Oct-19 | Private Sale (Planned) | 5,275 | $27.90 | $147,172.00 | (6%) 81.92K to 76.65K | |
| 03-Jul-19 4:24 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 02-Jul-19 | Private Sale (Planned) | 10,450 | $15.94 | $166,608.00 | (11%) 92.37K to 81.92K | |
| 21-Dec-18 5:11 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 20-Dec-18 | Market Purchase | 10,000 | $6.07 | $60,700.00 | 12% 82.37K to 92.37K | 30% |
| 21-Dec-18 5:11 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 19-Dec-18 | Grant | 82,372 | -- | -- | 100% 0 to 82.37K | |
| 31-May-18 5:14 PM View: | Cempra, Inc. (MLNT) | 29-May-18 | Private Purchase | 40,000 | $5.00 | $200,000.00 | 615% 6.5K to 46.5K | |
| 16-May-16 4:13 PM View: | United Therapeutics Corp. (UTHR) | 13-May-16 | Disposition | 111,250 | $111.48 | $12,402,200.00 | (99%) 112.79K to 1.54K | (93%) |
| 16-May-16 4:13 PM View: | United Therapeutics Corp. (UTHR) | 13-May-16 | Option Exercise | 111,250 | $70.09 | $7,798,020.00 | 7215% 1.54K to 112.79K | |
| 30-Dec-15 4:02 PM View: | United Therapeutics Corp. (UTHR) | 29-Dec-15 | Disposition | 2,000 | $159.23 | $318,460.00 | (59%) 3.38K to 1.38K | (35%) |
| 30-Dec-15 4:02 PM View: | United Therapeutics Corp. (UTHR) | 29-Dec-15 | Option Exercise | 2,000 | $65.80 | $131,600.00 | 145% 1.38K to 3.38K | |
| 23-Dec-15 4:05 PM View: | United Therapeutics Corp. (UTHR) | 22-Dec-15 | Disposition | 2,000 | $157.93 | $315,860.00 | (59%) 3.38K to 1.38K | (36%) |
| 23-Dec-15 4:05 PM View: | United Therapeutics Corp. (UTHR) | 22-Dec-15 | Option Exercise | 2,000 | $65.80 | $131,600.00 | 145% 1.38K to 3.38K |